Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Furosemide Injection
Status: Currently in Shortage
»Date first posted:
04/07/2020
»Therapeutic Categories: Cardiovascular
Accord Healthcare Inc. (Reverified 06/22/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08) | Unavailable | Estimated recovery: TBD; NDC is non-exempt | Requirements related to complying with good manufacturing practices |
| Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) | Unavailable | Estimated recovery: TBD; NDC is non-exempt | Requirements related to complying with good manufacturing practices |
| Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43) | Unavailable | Estimated recovery: TBD; NDC is non-exempt | Requirements related to complying with good manufacturing practices |
Avet Pharmaceuticals, Inc. (Reverified 07/01/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41) | Available | ||
| Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42) | Unavailable | Estimated recovery: late September 2026; Manufacturing delay | Other |
| Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44) | Unavailable | Estimated recovery: 9/30/2026; Manufacturing delay | Other |
Baxter Healthcare (Reverified 07/02/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25) | Available | ||
| Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25) | Available | ||
| Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25) | Available |
Eugia US LLC (Revised 06/16/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25) | Unavailable | Estimated recovery: TBD; Check wholesalers for inventory | Demand increase for the drug |
| Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25) | Available | Check wholesalers for inventory | |
| Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25) | Available | Check wholesalers for inventory |
Fresenius Kabi USA, LLC (Reverified 06/17/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02) | Available | Check wholesalers for inventory | |
| Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04) | Available | Check wholesalers for inventory | |
| Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10) | Available | Check wholesalers for inventory |
Gland Pharma Limited (Reverified 06/12/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02) | Unavailable | Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product | Discontinuation of the manufacture of the drug |
| Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04) | Unavailable | Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product | Discontinuation of the manufacture of the drug |
| Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10) | Unavailable | Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product | Discontinuation of the manufacture of the drug |
Hospira, Inc., a Pfizer Company (Reverified 06/25/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02) | Available | ||
| Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04) | Available | ||
| Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10) | Available | ||
| Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25) | Unavailable | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26) | Unavailable | Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
| Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27) | Unavailable | Next Delivery and Estimated Recovery: December 2028 | Other |
Meitheal Pharmaceuticals, Inc. (Revised 04/23/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03) | Available | Check wholesalers for inventory | |
| Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05) | Available | Check wholesalers for inventory | |
| Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11) | Available | Check wholesalers for inventory |